GC/MS analysis of anandamide and quantification of N- arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 1959-1968

  Yang, Hsiu Ying T ^a   Karoum, Farouk ^a   Felder, Christian ^b   Badger, Henry ^a   Wang, Tao Chin Lin ^a   Markey, Sanford P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Anandamide; Deuterium labeling; Endogenous cannabinoid; Gas chromatography mass spectrometry; N Arachidonoylphosphatidylethanolamides; Reverse phase C 18 cartridge

Indexed keywords

ACETIC ACID ETHYL ESTER; ANANDAMIDE; CHLOROFORM; N ARACHIDONOYLPHOSPHATIDYLETHANOLAMIDE; PHOSPHODIESTERASE; PHOSPHOLIPASE D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CHEMICAL BINDING; DIAGNOSTIC VALUE; ENZYME SPECIFICITY; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; SEQUENCE ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; ARACHIDONIC ACIDS; BRAIN CHEMISTRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; PHOSPHATIDYLETHANOLAMINES; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPLEEN; TESTIS;

ANIMALIA; SUIDAE;

EID: 0033048369     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721959.x     Document Type: Article

References (38)

1. Berdyshev E. V., Boichot E., and Lagente V. (1996) Anandamide - a new look on fatty acid ethanolamides. J. Lipid Mediat. Cell Signal. 15, 49-67.
2. Bisogno T., Ventriglia M., Milone A., Mosca M., Cimino G., and Di Marzo V. (1997) Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus. Biochim. Biophys. Acta 1345, 338-348.
3. Cadas H., Gaillet S., Beltramo M., Venance L., and Piomelli D. (1996a) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci. 16, 3934-3942.
4. Cadas H., Schinelli S., and Piomelli D. (1996b) Membrane localization of N-acylphosphatidylethanolamine in central neurons: studies with exogenous phospholipases. J. Lipid Mediat. Cell Signal. 14, 63-70.
5. Cadas H., di Tomaso E., and Piomelli D. (1997) Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17, 1226-1242.
6. Deutsch D. G. and Chin S. A. (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46, 791-796.
7. Deutsch D. G., Goligorsky M. S., Schmid P. C., Krebsbach R. J., Schmid H. H., Das S. K., Dey S. K., Arreaza G., Thorup C., Stefano G., and Moore L. C. (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100, 1538-1546.
8. Devane W. A. and Axelrod J. (1994) Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. USA 91, 6698-6701.
9. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
10. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J. C., and Piomelli D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
11. Felder C. C. and Glass M. (1998) Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 38, 179-200.
12. Felder C. C., Briley E. M., Axelrod J., Simpson J. T., Mackie K., and Devane W. A. (1993) Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 90, 7656-7660.
13. Felder C. C., Nielsen A., Briley E. M., Palkovits M., Priller J., Axelrod J., Nguyen D. N., Richardson J. M., Riggin R. M., Koppel G. A., Paul S. M., and Becker G. W. (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 393, 231-235.
14. Fontana A., Di Marzo V., Cadas H., and Piomelli D. (1995) Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines. Prostaglandins Leukot. Essent. Fatty Acids 53, 301-308.
15. Gilbert P. E. (1981) A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal dog. J. Clin. Pharmacol. 21 (Suppl.), 311S-319S.
16. Giuffrida A. and Piomelli D. (1998) Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett. 422, 373-376.
17. Herkenham M. (1991) Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections. NIDA Res. Monogr. 112, 129-145.
18. Imamura S. and Horiuti Y. (1979) Purification of Streptomyces chromofuscus phospholipase D by hydrophobic affinity chromatography on palmitoyl cellulose. J. Biochem. (Tokyo) 85, 79-95.
19. Kempe K., Hsu F.-F., Bohrer A., and Turk J. (1996) Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J. Biol. Chem. 271, 17287-17295.
20. Koga D., Santa T., Fukushima T., Homma H., and Imai K. (1997) Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues. J. Chromatogr. B Biomed. Sci. Appl. 690, 7-13.
21. Kruszka K. K. and Gross R. W. (1994) The ATP-and CoA-independent synthesis of arachidonoylethanolamide. J. Biol Chem. 269, 14345-14348.
22. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-273.
23. Natarajan V., Schmid P. C., and Schmid H. H. (1986) N-Acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim. Biophys. Acta 878, 32-41.
24. Schmid H. H. O., Schmid P. C., and Natarajan V. (1990) N-Acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29, 1-43.
25. Schmid H. H. O., Schmid P. C., and Natarajan V. (1996) The N-acylation-phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids 80, 133-142.
26. Schmid P. C., Reddy P. V., Natarajan V., and Schmid H. H. O. (1983) Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J. Biol. Chem. 258, 9302-9306.
27. Schmid P. C., Deli E., and Schmid H. H. (1995a) Generation and remodeling of phospholipid molecular species in rat hepatocytes. Arch. Biochem. Biophys. 319, 168-176.
28. Schmid P. C., Krebsbach R. J., Perry S. R., Dettmer T. M., Maasson J. L., and Schmid H. H. O. (1995b) Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375, 117-120.
29. Schmid P. C., Kuwae T., Krebsbach R. J., Schmid H. H., Matsuda S., Kanemitsu N., Nakamura A., Mimura Y., Ueda N., Kurahashi Y., and Yamamoto S. (1997a) Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. Chem. Phys. Lipids 87, 103-110.
30. Schmid P. C., Paria B. C., Krebsbach R. J., Schmid H. H. O., and Dey S. K. (1997b) Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. USA 94, 4188-4192.
31. Schmid P. C., Schwindenhammer D., Krebsbach R. J., and Schmid H. H. (1998) Alternative pathways of anandamide biosynthesis in rat testes. Chem. Phys. Lipids 92, 27-35.
32. Sepe N., De Petrocellis L., Montanaro F., Cimino G., and Di Marzo V. (1998) Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry. Biochim. Biophys. Acta 1389, 101-111.
33. Shaikh N. A. (1994) Assessment of various techniques for the quantitative extraction of lysophospholipids from myocardial tissues. Anal. Biochem. 216, 313-321.
34. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., Ishima Y., and Waku K. (1996a) Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. Eur. J. Biochem. 240, 53-62.
35. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., and Waku K. (1996b) Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. Blochem. Biophys. Res. Commun. 218, 113-117.
36. Ueda N., Kurahashi Y., Yamamoto S., and Tokunaga T. (1995) Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270, 23823-23827.
37. Vogel Z., Barg J., Levy R., Saya D., Heldman E., and Mechoulam R. (1993) Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61, 352-355.
38. Yaksh T. L. (1981) The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. J. Clin. Pharmacol. 21 (Suppl.), 334S-340S.